patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
Published 5 years ago • 209 plays • Length 28:28Download video MP4
Download video MP3
Similar videos
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
3:24
sequencing of therapies in egfr-mutant nsclc
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc
-
4:56
patient selection for osimertinib; thoughts on sequencing
-
3:27
egfr-mutant nsclc: selecting patients for osimertinib
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
2:50
sequencing with osimertinib in egfr-mutated nsclc
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
3:57
sequencing with osimertinib in egfr-positive nsclc
-
1:00:53
drs. sepesi & cascone discuss egfr-targeted therapy in early-stage nsclc: https://bit.ly/3ozllfo
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
2:00
dr. goldberg on sequencing following treatment with osimertinib in nsclc
-
59:03
navigating rapid changes in first- and later-line treatment of egfr-mutated nsclc
-
57:37
emerging role of egfr-targeted therapy in resectable lung cancer
-
1:00:20
it’s precisely the time for more precision in genomic testing and targeted treatment of nsclc
-
1:02:08
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc